Biomerica fourth-quarter sales jump 17% as fiscal 2026 loss improves 24%

Verifying
  • Biomerica reported higher fourth-quarter sales and an improved fiscal-year net loss.
  • 17%: Fourth-quarter net sales rose to approximately $875,000 from $749,000.
  • Biomerica completed a $2.23 million financing after the May 31 fiscal year-end.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.